Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy - Jennie Lugassy; Noor Abdala-Saleh; Ghada Jarrous; Abeer Turky; Daniel Saidemberg; Gabriela Ridner-Bahar; Nir Berger; Dana Bar-On; Tetsuya Taura; David Wilson; Nathan Karin (Proceedings of the National Academy of Sciences, 2025)